bioRxiv · 10.1101/2021.06.12.448202
Comparative therapeutic strategies for preventing aortic rupture in a mouse model of vascular Ehlers Danlos syndrome
Abstract
We created a knock-in Col3a1+/G182R mouse model with spontaneous mortality caused by thoracic aortic rupture that recapitulates a rare vascular genetic disease of type III collagen, the vascular Ehlers-Danlos syndrome (vEDS). Investigation of this model showed lower survival rate in males caused by aortic rupture, thin non-inflammatory arteries and altered arterial collagen. Transcriptomic analysis of aortas showed upregulation of genes related to inflammation and cell stress response. Compared to water, survival rate of Col3a1+/G182R mice was not affected by beta-blockers (propranolol or celiprolol). Two other vasodilating anti-hypertensive agents (hydralazine, amlodipine) gave opposite results on aortic rupture and mortality rate. There was a spectacular beneficial effect of losartan, reversed by the cessation of its administration, and a marked deleterious effect of exogenous angiotensin II. These results suggest that blockade of the renin angiotensin system should be tested as a first-line medical therapy in patients with vEDS.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Legrand, A., Guery, C., Faugeroux, J., Fontaine, E., Gianfermi, A., Ferreira, I., Verpont, M.-c., Adham, S., Mirault, T., Hadchouel, J., Jeunemaitre, X.. 2021-06-12. Comparative therapeutic strategies for preventing aortic rupture in a mouse model of vascular Ehlers Danlos syndrome. https://doi.org/10.1101/2021.06.12.448202
Cite the original work for its findings. Save a collection to share your selection of sources.